miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators of gene expression implicated in cancer progression.
• Colorectal cancer (CRC) metastasis significantly reduces patient survival, highlighting the need for prognostic markers and therapeutic targets.
• Transforming growth factor-beta (TGF-β) signaling plays a complex role in cancer, including promoting metastasis.

Purpose of the Study:

• To investigate the role of miR-1269a in colorectal cancer (CRC) metastasis.
• To elucidate the relationship between miR-1269a and TGF-β signaling in CRC.
• To evaluate miR-1269a as a prognostic marker and therapeutic target for CRC.

Main Methods:

• Analysis of miR-1269a expression in late-stage CRC tissues.
• Long-term monitoring of 100 stage II CRC patients to correlate primary tumor miR-1269a expression with relapse and metastasis.
• In vivo and in vitro experiments assessing the impact of miR-1269a on CRC cell invasion and metastasis.
• Investigation of the molecular mechanisms linking miR-1269a and TGF-β signaling, including target gene analysis (Sox4, Smad7, HOXD10).

Main Results:

• miR-1269a is upregulated in late-stage CRCs.
• High miR-1269a expression in primary tumors of stage II CRC patients strongly correlates with increased risk of relapse and metastasis.
• miR-1269a significantly enhances CRC cell invasion and metastasis in vivo.
• A positive feedback loop exists where TGF-β activates miR-1269a via Sox4, and miR-1269a enhances TGF-β signaling by targeting Smad7 and HOXD10.

Conclusions:

• miR-1269a promotes colorectal cancer metastasis.
• miR-1269a serves as a significant prognostic marker for CRC relapse and metastasis risk.
• The miR-1269a/TGF-β feedback loop represents a potential therapeutic target for inhibiting CRC metastasis and improving patient outcomes.